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The following conclusions are derived from an epidemiological study. Reduced repair of ultraviolet
(UV)-induced DNA damage contributes directly to basal cell carcinoma (BCC) in individuals with
prior sunlight overexposure. A family history of BCC is a predictor of low DNA repair. Repair of
UV-damaged DNA declines at a fixed rate of approximately 1 % per annum in noncancerous
controls. The DNA repair differences between young BCC cases and their controls disappear as
they age. Hence, BCC, in terms of DNA repair, is a premature aging disease. The persistence of
photochemical damage because of reduced repair results in point mutations in the p53 gene and
allelic loss of the nevoid BCC gene (Gorlin's syndrome) located on chromosome 9q. The fact that
environmental vulnerability is gender oriented implicates hormones in regulating DNA repair.
Xeroderma pigmentosum appears to be a valid paradigm for the role of DNA repair in BCC in the
general population. - Environ Health Perspect 105(Suppl 4):927-930 (1997)
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Introduction
Human populations typically display a
range ofinherent sensitivities to radiation
and chemical carcinogens. Such variability
in host response may be due in part to
inherent differences between individual
ability to monitor and repair damaged sites
induced in their genetic material by exoge-
nous and endogenous genotoxic agents. A
human model supporting such an assump-
tion exists with the rare, cancer-prone
inherited disorder xeroderma pigmento-
sum (XP) (1,2). XP patients experience a
greater than 1000-fold excess frequency of
sunlight-related skin cancers. Coupled to
this marked susceptibility is the consistent
laboratory finding that all cells tested from
XP patients are defective in repairing DNA
damage induced by ultraviolet (UV)
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radiation and other UV-mimetic agents.
Because the UV component ofsolar radia-
tion exists as the predominant environ-
mental risk factor for skin cancer, a causal
association between UV exposure, defective
repair ofUV-induced DNA photoprod-
ucts, and skin cancer is inferred. The link
is further strengthened by clinical reports
showing that the occurrence ofskin tumors
is practically ameliorated in XP patients
afforded early and lifelong protection from
sunlight exposure (3,4).
Taken together, these observations
show that DNA repair capacity (DRC)
could exist as an etiologic correlate of
cancer risk outside ofXP. IfXP is consid-
ered to represent the lower range ofrepair
capabilities in humans, those individuals
expressing a somewhat reduced repair
response within the upper quadrant or
shoulder of a dose-response curve (hall-
mark of repair) may be at increased risk
for skin cancer or internal neoplasms
given an appropriate exposure. Because it
can be anticipated that human popula-
tions may include individuals who show
only marginal damage vulnerability, any
repair assay must be able to detect the
level of DRC found in the heterozygotes
of autosomal recessive DNA repair dis-
eases with extreme precision and minimal
intraassayvariation.
The extent to which this hypothesis
may be evaluated is dependent on the
availability ofvalidated laboratory method-
ology with which to measure DNA repair
proficiency within study populations of
interest. Such laboratory methodology has
been developed and validated with over
450 subjects in case-control studies.
Methods and Results
T-lymphocytes isolated from subjects'
peripheral bloodwere assayed (Figure 1) for
their DRC (5). The assays used plasmid
DNA containing photoproducts resulting
from three UV doses and were carried out
in triplicate for each dose from 0, 350, to
700 J/m2. The results are reported as the
percent of cat gene expression (% CAT
activity) following repair ofdamaged DNA
compared to undamaged plasmid DNA.
Lymphoblasts from patients with XP-A
(Group A, most severe), XP-D (Group D,
severe), and XP-C (Group C, classic form)
provided the standard DNA repair of
known levels ofdeficiency curves. Also,
lymphoblasts from normal individuals
(GM0131 and GM1892) were induded in
the standard normal repair curves. The
DRC measurements obtained at UV doses
of 700 J/m2 (26 pyrimidine dimers per
DNA molecule) and 350 J/m2 generated
straight line functions. Under these circum-
stances only the measurements at a dose of
700J/m2were usedforgroup comparisons.
The participants consisted of 88 cases
with primary basal cell carcinoma (BCC)
as diagnosed through the dermatopath-
ology laboratory of the Johns Hopkins
Hospital, which serves multiple practicing
dermatologists in Maryland. The 135 com-
parison controls had skin biopsies for diag-
nosis of mild skin disorders such as
seborrheic keratoses, intradermal nevus, or
subacute eczematous dermatitis. All sub-
jects were between 20 and 60 years ofage,
lived in Baltimore Cityor its suburban area
for most oftheir lives, and had skin biop-
sies in 1987 to 1990. The purpose of
selecting only young subjects was to maxi-
mize the difference in risk factor between
cases and controls. At a clinic visit, derma-
tologists examined all participants to
dassify skin type and describe current skin
conditions. The subjects then gave written
informed consent, completed a structured
questionnaire, and provided blood. Control
individuals with a self-reported history
or clinical signs of skin cancer or other
cancers wereexcluded.
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was somewhat short of being statistically
significant with a p value of0.097. In pre-
vious reports (5,6) we used 50% ofcontrol
DRC levels as a cutoffvalue to facilitate
the evaluation of modification effects on
DRC. In this analysis we tried to find a
EcoRI
Genotoxic
damage
0 cat
EcoRI
DEAE-dextran
EcoRI
Hindill
T-Lymphocytes
Damage
removal
Excised
fragment
Chl
ace
73H-acetyl-CoA
Lchloramphenicol
"I,* Restored cat gene
.2-6N&7ZZ@-Z@(
loramphenicol
etyltransferase
4/ 3H-Mono- and di- 7
- acetylated
chloramphenicol _
Figure 1. Schematic illustration of the DNA repair capacity assay. Full details are found in Athas et al. (5) and
Wei et al. (6).
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Figure 2. Percentage distribution of DNA repair capacity.
cutoffvalue of DRC to maximize the risk
for BCC. We found that individuals who
had a DNA repair level below the 30th
percentile of the controls had a greater
than 2-fold increased risk for BCC [odds
ratio, 2.3; 95% CI, 1.2-4.5; adjusted for
age (based on two-sided Student's t test)].
AgeStratification
The DRC of the subjects declined with
age over the 20- to 60-year span studied
(6). This age-related decline (apoptosis)
occurred in both cases and controls,
although it only reached significant decline
in the controls (Figure 3). In the 106 con-
trols, lacking any family history of skin
cancer or presence of any premalignant
skin lesions, the decline is 0.63% per year
between 20 and 60 years of age. This
would amount to about a 25% decrease in
cumulative DRC over a 40-year period.
This age-related decline in DNA repair
should be accompanied by an increased
accumulation ofpersistent DNA damage
affecting an increase in mutation fixation in
structural and functional proteins. The
mutation rate accompanying aging in the
hprtgene in human lymphocytes is report-
edly between 1.3 and 1.6% per year (7),
twice the rate of decline of DNA repair
reported here. Many known genetically
linked repair-deficiency diseases, such as
Cockayne's syndrome andXP, also manifest
premature aging (8). In XP patients, the
defect in DRC is associated with age-related
skin changes and development of skin
cancer 20 years earlier than in the normal
population (2). Other workers have
reported age-related changes in unscheduled
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Figure 3. Relationship between age at first occurrence
of basal cell carcinoma and DNA repair capacity.
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Low DNARepair Capacity
as aRiskFactor
In general,- individual DRC values varied
in this population. Compared to controls,
the DRC of cases was shifted to the low
end ofthe range (Figure 2). The cases had
a mean DRC (7.4%) lower than that ofthe
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DNA synthesis (UDS) in lymphocytes
(9,10) and epidermal cells (from blood
donors, especially in the aged). These find-
ings are consistent with the age-related
dedine in DRC observed in this study.
We found an age-related decline in
post-UV DRC of-0.6% per year in cul-
tured primary skin fibroblasts from normal
donors from the first to the tenth decade of
life. There was a corresponding age-related
increase in post-UV mutability measured
as mutations into transfected UV-treated
plasmid (pSP189) of + 0.6% per year in
lymphoblastoid cell lines from normal
donors ofthe same age range. This study
indicates that aging in humans is associated
with decreasing ability to process new UV-
induced DNA damage and this age-related
reduction in DRC and increase in mutabil-
ity is reflected in cultured skin and blood
cells (11).
Similar to the XP model, BCC cases
with first skin cancer at an early age repair
DNA photoproducts poorly compared to
controls or with cases expressing BCC at a
later age ofonset. This suggests that poor
DNA repair is associated with the preco-
cious aging manifested by an early onset of
BCC. After adjusting for age at onset, the
age-related dedine in the repair ofUVdam-
age among the cases was at least as sharp as
that ofcontrols after adjustment for the age
at onset offirst cancer. After controlling for
current age, the age of onset of BCC was
positively correlatedwith DNArepair.
Familial History
Several findings suggest that the early age
ofonset ofskin cancer and the reduction of
DRC have familial links. Control subjects
with a family history of BCC or with
actinic keratoses had low DNA repair levels
similar to those ofthe cases. After remov-
ing these positive controls, the overall dif-
ference in DNA repair between cases and
controls was statistically significant.
Among those cases between the ages of
20 and 44 having BCC (n= 38), about
45% had a family history ofBCC whereas
only 10% ofcases who had BCC at ages 55
to 60 (n=21) had a similar history. This
trend was statistically significant. In con-
trast, only 16% ofcontrols (n= 135) had a
previous skin cancer history.
MultiplicityofTumors
Multiple linear regression models were used
(Figure 4) to correlate DRC with the num-
ber ofskin cancers (least-square estimate of
regression coefficient from multiple linear
regression models). The estimated odds
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Figure 4. Relationship between DNA repair capacity
andthe number of basal cell carcinomas.
ratio was used to describe the risk ofBCCs.
The distribution of DRCs of the subjects
was approximately normal, with a 5-fold
variation between individuals. DRCs below
the upper 30th percentile ofcontrols were
associated with an estimated 2.3-fold (95th
CI, 1.17 to 4.54-fold) increased risk for the
occurrence ofBCCs. The lower the DRC,
the greater the number of skin tumors
in individuals (p<0.05) after adjustment
for age.
SunlightExposure
A fundamental question is whether the
genotoxicant-DNA repair paradigm ofXP
reflects the carcinogenic response ofindivid-
uals who have relatively marginal reduction
in DRC but who have oversaturated this
capacity with excessive sunlight exposure
(Figure 5). In this case-control study, the
proportion of cases (36%) that have been
overexposed in their lifetime is double that
ofthe controls (17%). The development of
BCC, therefore, probably reflects the
mutation fixation as a consequence ofthe
persistent DNA damage resulting from
individuals having exceeded their DRC.
After UV exposure, subjects with a family
history ofskin cancer, possiblywith reduced
repair capacity compared to others of the
same age, will develop this disease at an
early age. It is implied in subjects displaying
a time-delayed onset ofBCC that mutation
fixation may also occur as a result ofaccu-
mulated, excessive unrepaired DNA dam-
age in individuals who possess apparently
normal DNA repair levels.
Gender Orientation
Stratification ofthe odds ratios according
to gender (Figure 5) revealed the vulnera-
bility to BCC of the skin ofwomen who
have a history ofoverexposure to sunlight
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Figure 5. Effect of DNA repair capacity on risk of basal
cell carcinoma by gender; relationship to the number of
severe sunburns in a lifetime.
and who have reduced repair capacity.
These results agree with those obtained in
the previous pilot study (5,6) in which
young women who have a long-standing
history ofsunbathing were predisposed to
BCC ofthe skin. This gender orientation
suggests an explanation in terms of hor-
monal, genetic, or combined factors. The
self-questionnaires included requests for
information concerning stages of estrous,
hormonal supplementation, and use oforal
contraceptives. Surprisingly, postmeno-
pausal women receiving estrogen supple-
mentation had a significant increase in
their DRC. These data show that hor-
mones can regulate DRC, although they
do not account for the inhibition of DNA
repair; but the data provide important
clues concerning agents that can turn on
DNA repair. These data are reflected in the
crossover ofrepair in Figure 3. When such
age-stratified data are further stratified
according to gender, the peculiar drop
among the female BCC patients is seen
among those who are premenopausal and
not on estrogen supplementation, whereas
the increase in repair characteristic of the
postmenopausal female cases appears to
reflect the large number ofsuch women on
estrogen supplementation.
MutationalConsequences
ofPersistent DNADamage
If DNA repair is a primary target for
apoptosis, we can anticipate that there
should be a corresponding increase in
damage persistence as a function ofaging.
These findings are supported by the obser-
vations ofCole et al. (7) ofa concomitant
increase in mutation fixation of a number
of genes at the rate corresponding to an
increase of 1 to 2% per annum over a wide
age range.
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The persistence of UV-induced photo-
products, attributed to reduced DNA
repair, was also studied at the level ofp53
genes in BCC (12). We analyzed 36 BCCs
for p53 mutations and a subset of these
tumors for loss of chromosomes 17p and
9q. Sixty-nine percent of the BCCs had
lost a 9q allele, with the common area of
loss surrounding the putative gene for
nevoid BCC, or Gorlin's syndrome. Forty-
four percent (16 of 36) of BCCs had a
mutatedp53 allele, usually opposite pyrim-
idine tracts, which is consistent with UV-
induced pyrimidine dimer and 6-4 adduct
generated mutations. Surprisingly, only one
tumor lost a 17p allele, and in all BCCs
only one p53 allele was inactivated. This is
in direct contrast to other epithelial tumors,
which usually progress by the inactivation
ofboth p53 alleles. It is possible that the
absence of clinical progression of BCC
may be related to the lack ofcomplete p53
inactivation in these tumors.
Condusions
The sunlight-BCC paradigm exemplifies
the causal relationship between a specific
kind ofdamage and the potential effects of
the persistence ofsuch damage in tumor
progression; it also provides mechanistic
insights into fundamental biological
processes. These studies open doors for
detailed examination of other forms of
chromosomal instability in familial chronic
diseases. Because the plasmid used in this
DRC assay is a useful target for a large
array of DNA-damaging agents it is feasi-
ble to extend these studies to a wide variety
ofdiseases with potential genetic linkages.
The only DNA damaging agents, in which
this assay is not useful, however, are those
that generate single- and double-strand
breaks, since only supercoiled DNA is
expressed in this assay system.
Many repair deficiency diseases, such as
XP, are associated with neurodegenerative
symptoms, suggesting relationships between
repair and chronic diseases other than can-
cer. Certainly the age relatedness ofmany
cancers may be a characteristic ofdeficient
DRC or mismatch repair. Defective or defi-
cient repair processes associated with aging
require that population and case-control
studies involving repair assure that age-
matching is incorporated into study proto-
cols. Further, it will be ofgreat interest to
determine which steps in the progression of
DRC or mismatch repair are rate limiting,
and to correlate organ specificity ofa disease
with specific steps in repair processes.
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